Saint Bartholomew's Hospital

London, England EC1A 7BE

1 studies enrolling now · 7 studies all time

What they study most

Bladder Cancer, Borderline Ovarian Serous Tumor, Childhood Extracranial Germ Cell Tumor, Childhood Teratoma, Choriocarcinoma, Extragonadal Embryonal Carcinoma, Extragonadal Seminoma, Germ Cell Tumor, Germinoma, Lymphoma, Malignant Germ Cell Neoplasm, Malignant Germ Cell Tumor

Studies at this site

• Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors — Recruiting now
• Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer — Completed
• Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors — Running, not enrolling
• Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer — Completed
• Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer — Completed
• Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia — Withdrawn before enrolling
• Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia — Completed